Innova Captab (NSE:INNOVACAP) Total Equity: ₹10,908 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INNOVACAP Innova Captab Ltd NSE:INNOVACAP
46 GF Score
Price ₹962.70
! 6 Warning Signs
View Full Analysis

What is Innova Captab Total Equity?

Innova Captab NSE:INNOVACAP -4.81% 46 Total Equity is ₹10,908 Mil as of Mar. 2026. GuruFocus rates NSE:INNOVACAP with a GF Score™ of 46/100. The stock has 6 warning signs investors should review.

Innova Captab's total equity for the quarter that ended in Mar. 2026 was ₹10,908 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Innova Captab Total Equity Historical Data

* Premium members only.

The historical data trend for Innova Captab's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innova Captab Total Equity Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial 2,086.06 2,765.06 8,308.94 9,594.17 10,907.92

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,594.17 0.00 10,211.42 0.00 10,907.92
NSE:INNOVACAP
46GF Score
Innova Captab Ltd NSE:INNOVACAP
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innova Captab Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Innova Captab's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=18373.79-7465.87
=10,908

Innova Captab's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=18373.79-7465.87
=10,908

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹10,908 Mil mean?
Innova Captab (NSE:INNOVACAP) has a Total Equity of ₹10,908 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Innova Captab and its competitors.
Is Innova Captab's Total Equity too high?
Innova Captab's current Total Equity is ₹10,908 Mil. Overall, Innova Captab has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Innova Captab's Total Equity compare to ZTS and UTHR?
Innova Captab's Total Equity of ₹10,908 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Innova Captab and its competitors. Innova Captab's current Total Equity is ₹10,908 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innova Captab stock overvalued right now?
Innova Captab (NSE:INNOVACAP) has a current Total Equity of ₹10,908 Mil. The current Total Equity is ₹10,908 Mil. Innova Captab's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Innova Captab (NSE:INNOVACAP), the current Total Equity is ₹10,908 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innova Captab Business Description

Other Exchanges 544067:India
Address Plot No.320, Industrial Area, Phase-1, Panchkula, HR, IND, 134113
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
46GF Score

Get the complete analysis for NSE:INNOVACAP

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹962.70
Price